Cargando…
Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
BACKGROUND: Phenylketonuria (PKU) is a chronic inborn error of amino acid metabolism that requires lifelong follow-up and intervention, which may represent strains on Quality of Life (QoL). This observational study evaluated QoL in a cohort of PKU patients, using updated and detailed instruments. ME...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265392/ https://www.ncbi.nlm.nih.gov/pubmed/25471331 http://dx.doi.org/10.1186/1471-2458-14-1243 |
_version_ | 1782348879091466240 |
---|---|
author | Cazzorla, Chiara Cegolon, Luca Burlina, Alessandro P Celato, Andrea Massa, Pamela Giordano, Laura Polo, Giulia Daniele, Aurora Salvatore, Francesco Burlina, Alberto B |
author_facet | Cazzorla, Chiara Cegolon, Luca Burlina, Alessandro P Celato, Andrea Massa, Pamela Giordano, Laura Polo, Giulia Daniele, Aurora Salvatore, Francesco Burlina, Alberto B |
author_sort | Cazzorla, Chiara |
collection | PubMed |
description | BACKGROUND: Phenylketonuria (PKU) is a chronic inborn error of amino acid metabolism that requires lifelong follow-up and intervention, which may represent strains on Quality of Life (QoL). This observational study evaluated QoL in a cohort of PKU patients, using updated and detailed instruments. METHODS: 22 patients with mild PKU respondent to BH(4) and 21 patients with classical PKU treated with diet were recruited in this study. Adult patients completed WHOQOL questionnaire-100 (WHOQOL-100) and pediatric patients the Pediatric QoL inventory (PedsQL(TM)). Psychiatric and mood disorders were also evaluated using TAD or BDI and STAI-Y inventories. A multivariable linear regression model was fitted to investigate the predictors of QoL, including age, sex, treatment type, length of current treatment, educational level and employment status (only for adults) as covariates. Results were presented as regression coefficients with 95% confidence interval. RESULTS: Global QoL scores were within normal range both in patients with mild and classical disease but global QoL scores were significantly higher in patients with mild PKU under BH(4) treatment as compared to those affected by classical disease who were under diet regimen. Furthermore, QoL significantly increased in long treated PKU patients. Among adult patients, QoL scores were significantly lower in males, in patients with lower education and in those employed or unemployed as compared to students (baseline). CONCLUSIONS: Both diet and medical treatment based upon BH(4) seem to be associated with higher QoL in the long run. However, patients with mild PKU can rely on BH(4) to achieve a higher Phe tolerance and a better compliance to therapy due to diet relaxation/avoidance. Some specific categories of patients with a lower QoL should be investigated more in depth, engaging with those at risk of lower treatment compliance. The questionnaires employed in the present study seemed to be able to effectively detect criticalities in QoL assessment and represent an advance from previous inventories employed in the past. |
format | Online Article Text |
id | pubmed-4265392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42653922014-12-15 Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria Cazzorla, Chiara Cegolon, Luca Burlina, Alessandro P Celato, Andrea Massa, Pamela Giordano, Laura Polo, Giulia Daniele, Aurora Salvatore, Francesco Burlina, Alberto B BMC Public Health Research Article BACKGROUND: Phenylketonuria (PKU) is a chronic inborn error of amino acid metabolism that requires lifelong follow-up and intervention, which may represent strains on Quality of Life (QoL). This observational study evaluated QoL in a cohort of PKU patients, using updated and detailed instruments. METHODS: 22 patients with mild PKU respondent to BH(4) and 21 patients with classical PKU treated with diet were recruited in this study. Adult patients completed WHOQOL questionnaire-100 (WHOQOL-100) and pediatric patients the Pediatric QoL inventory (PedsQL(TM)). Psychiatric and mood disorders were also evaluated using TAD or BDI and STAI-Y inventories. A multivariable linear regression model was fitted to investigate the predictors of QoL, including age, sex, treatment type, length of current treatment, educational level and employment status (only for adults) as covariates. Results were presented as regression coefficients with 95% confidence interval. RESULTS: Global QoL scores were within normal range both in patients with mild and classical disease but global QoL scores were significantly higher in patients with mild PKU under BH(4) treatment as compared to those affected by classical disease who were under diet regimen. Furthermore, QoL significantly increased in long treated PKU patients. Among adult patients, QoL scores were significantly lower in males, in patients with lower education and in those employed or unemployed as compared to students (baseline). CONCLUSIONS: Both diet and medical treatment based upon BH(4) seem to be associated with higher QoL in the long run. However, patients with mild PKU can rely on BH(4) to achieve a higher Phe tolerance and a better compliance to therapy due to diet relaxation/avoidance. Some specific categories of patients with a lower QoL should be investigated more in depth, engaging with those at risk of lower treatment compliance. The questionnaires employed in the present study seemed to be able to effectively detect criticalities in QoL assessment and represent an advance from previous inventories employed in the past. BioMed Central 2014-12-04 /pmc/articles/PMC4265392/ /pubmed/25471331 http://dx.doi.org/10.1186/1471-2458-14-1243 Text en © Cazzorla et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Cazzorla, Chiara Cegolon, Luca Burlina, Alessandro P Celato, Andrea Massa, Pamela Giordano, Laura Polo, Giulia Daniele, Aurora Salvatore, Francesco Burlina, Alberto B Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria |
title | Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria |
title_full | Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria |
title_fullStr | Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria |
title_full_unstemmed | Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria |
title_short | Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria |
title_sort | quality of life (qol) assessment in a cohort of patients with phenylketonuria |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265392/ https://www.ncbi.nlm.nih.gov/pubmed/25471331 http://dx.doi.org/10.1186/1471-2458-14-1243 |
work_keys_str_mv | AT cazzorlachiara qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT cegolonluca qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT burlinaalessandrop qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT celatoandrea qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT massapamela qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT giordanolaura qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT pologiulia qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT danieleaurora qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT salvatorefrancesco qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria AT burlinaalbertob qualityoflifeqolassessmentinacohortofpatientswithphenylketonuria |